Table 4.
Spine SBRT Cohorts.
Study (Year) | No. of Patients | Dose/No. of Fractions(#) | Local Control | Pain Control | ≥Grade 3 Toxicities |
---|---|---|---|---|---|
Chang et al. 2009 [66] | 129 | 16–39 Gy/1–5# | 69% at 3 years | 91% | No toxicity |
Schipani et al. 2011 [67] | 124 | 18 Gy/1# | 92% at 3 years | 92% | No toxicity |
Wang et al. 2012 [68] | 149 | 27–30 Gy/3# | 72% at 2 years | 86% | Acute 9% (pain, GI, fatigue) |
Guckenburger et al. 2014 [69] | 301 | Median 24 Gy/3# | 84% at 2 years | Not reported | Acute 0.01% (pain) |
Bishop et al. 2015 [70] | 285 | 18–27 Gy/1–3# | 82% at 3 years | Not reported | Not reported |
Bernard et al. 2017 [71] | 127 | Median 27 Gy/3# | 76% at 2 years | Not reported | 6.75% Spine fracture |